The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Healthcare favorites for long-term growth

 Mar 04, 2009 07:00 PM UTC
Return Risk
+5.65% MID
Tracked Blogger
Symbol Sentiment Start Return Closed
JNJ Positive 03/04/09 +3.91% 04/29/09
AZN Positive 03/04/09 +24.21% 05/14/09

Graphic_arrow1 Via BloggingStocks:  

Filed under: Newsletters, Johnson and Johnson (JNJ), Stocks to Buy

"Long-time healthcare investors can be forgiven their confusion; drug stocks are supposed to be defensive, but many of the largest drugmakers have been pounded," observes Richard Moroney.


Nevertheless, in the blue chip Dow Theory Forecasts, the advisor sees two favorite healthcare and pharmaceutical issues as long-term opportunities: AstraZeneca (NYSE: AZN) and Johnson & Johnson (NYSE: JNJ).


Moroney explains, "Healthcare companies' profits are supposed to remain fairly steady regardless of the economic situation. But hospitals' capital spending fell in the December quarter, and many consumers are putting off medical care because they cannot afford it.

Continue reading Healthcare favorites for long-term growth

Healthcare favorites for long-term growth originally appeared on BloggingStocks on Wed, 04 Mar 2009 14:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments



Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati



 Graphic_website1 Read the rest of original post »



Comments (1)

Add Comment

Arrow_up
Arrow_down
sellreplicawatch   N/A     1 point   commented 23 days ago reply

high quality replica watches of well known brands - Jacob & Co, TAG Heuer, Cartier, Panerai and much more.

*If you want to buy replica watch, you have come to the right place! We are leading supplier of all kinds of REPLICA WATCHES.


Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch